Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis
Clinical trial NCT05572567 · COMPLETED
Trial details
- NCT number
- NCT05572567
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-10
- Primary completion
- 2022-10-10
- Enrollment
- 1972
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.